Matches in Nanopublications for { ?s ?p "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP764467.RAVLXJAroFv8EFw1bc8fZ49fadJqSvCvp8AuVXemh0e6g130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764467.RAVLXJAroFv8EFw1bc8fZ49fadJqSvCvp8AuVXemh0e6g130_provenance.
- NP1018519.RAaGhB4mghGZcr64xcFBVAIS5WnnvrilwufqGKBCSqQKs130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018519.RAaGhB4mghGZcr64xcFBVAIS5WnnvrilwufqGKBCSqQKs130_provenance.
- assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1103672.RAfnai5u_3ijtuImA5UIQ9yX7FEH8inia3aUQ_U_6byhg130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1103672.RAfnai5u_3ijtuImA5UIQ9yX7FEH8inia3aUQ_U_6byhg130_provenance.
- NP286388.RAOnxn5xOaGTBPw0Ha7lD6WtUx7aPAKIEZMUeo3Ir_QpM130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286388.RAOnxn5xOaGTBPw0Ha7lD6WtUx7aPAKIEZMUeo3Ir_QpM130_provenance.
- NP1103671.RA3wQxDd9QK-NEeB_33eBfvyywiKNumooKVoO0a9zcLSU130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1103671.RA3wQxDd9QK-NEeB_33eBfvyywiKNumooKVoO0a9zcLSU130_provenance.
- NP1103673.RA3I4i_OuK8_RCvwco1jv_GiC1jaemFi0hAMBHRoEM7RQ130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1103673.RA3I4i_OuK8_RCvwco1jv_GiC1jaemFi0hAMBHRoEM7RQ130_provenance.